The relationship between atherogenic index of plasma and epicardial adipose tissue in hemodialysis and peritoneal dialysis patients

Renal Failure

Volumn 35, Issue 9, 2013, Pages 1193-1198

  Erdur, Mehmet Fatih ^a   Tonbul, Halil Zeki ^a   Ozbiner, Huseyin ^a   Ozcicek, Adalet ^b   Ozcicek, Fatih ^b   Akbas, Emin Murat ^b   Ozbek, Orhan ^a   Hamur, Hikmet ^b   Turkmen, Kultigin ^b  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b ERZINCAN UNIVERSITY   (Turkey)

Author keywords

Atherogenic index of plasma; End stage renal disease; Epicardial adipose tissue; High density lipoprotein; Triglyceride

Indexed keywords

ALBUMIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROGENIC INDEX OF PLASMA; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; ELECTROCARDIOGRAM; EPICARDIAL ADIPOSE TISSUE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHROLITHIASIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADIPOSITY; ADULT; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84884255342     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.823826     Document Type: Article

References (38)

1. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: Time to end the ''only-50%'' myth. Arch Intern Med. 2001;161(22):2657-2660
2. Sarnak MJ, Coronado BE, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002; 57(5):327-335
3. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-Analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829-1839
4. Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment. Am J Nephrol. 2008;28(6):958-973
5. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes. 2002;51(4):1226-1232
6. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: The Quebec cardiovascular study. Atherosclerosis. 2000;153(2): 263-272
7. Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis. 1993;21(6):573-592
8. Ho E, Shimada Y. Formation of the epicardium studied with the scanning electron microscope. Dev Biol. 1978;66(2):579-585
9. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003; 108(20):2460-2466
10. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1
11. Kremen J, Dolinkova M, Krajickova J, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: Possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006; 91(11):4620-4627
12. Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond).2008;32(2):268-274
13. Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue: Comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond). 2008;32(5):810-815
14. Turkmen K, Ozbek O, Kayikcioglu H, et al. The relationship between epicardial adipose tissue and coronary artery calcification in peritoneal dialysis patients. Cardiorenal Med. 2012;2(1):43-51
15. Tonbul HZ, Turkmen K, Kayikcioglu H, Ozbek O, Kayrak M, Biyik Z. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients. Ren Fail. 2011;33(8):770-775
16. Turkmen K, Kayikcioglu H, Ozbek O, et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/ calcification syndrome in ESRD patients. Clin J Am Soc Nephrol. 2011;6(8):1920-1925
17. Frohlich J, Dobiasova M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873-1880
18. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583-588
19. Schlett CL, Massaro JM, Lehman SJ, et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond). 2009; 33(2):226-232
20. Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003;325(4):163-167
21. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112-S119
22. Dobiasova M, Stribrna J, Sparks DL, Pritchard PH, Frohlich JJ. Cholesterol esterification rates in very low density lipoprotein-And low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arterioscler Thromb. 1991;11(1):64-70
23. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276(11):882-888
24. Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis. 2000;35(5):852-862
25. Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol. 1995; 5(9):1703-1708
26. Docci D, Capponcini C, Mengozzi S, Baldrati L, Neri L, Feletti C. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron. 1995;69(3): 323-326
27. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245-252
28. Kronenberg F, Lingenhel A, Neyer U, et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl. 2003;(84):S113-S116
29. Siamopoulos KC, Elisaf M. Is CAPD atherogenic? Perit Dial Int. 1997;17(3):227-231
30. Heimburger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron. 1996;72(2):135-144
31. Babazono T, Nakamoto H, Kasai K, et al. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol. 2007;27(4):409-415
32. Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: The effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes. 1990;14(12):1013-1022
33. Wang TD LW, Chen MF. Epicardial adipose tissue measured by multidetector computed tomography: Practical tips and clinical implications. Acta Cardiol. 2010;26:55-68.
34. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899-1911
35. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factoralpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102(21):2636-2642
36. Yildiz A, Tepe S, Oflaz H, et al. Carotid atherosclerosis is a predictor of coronary calcification in chronic hemodialysis patients. Nephrol Dial Transplant. 2004;19(4):885-891
37. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20(8):1676-1685
38. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996;49(5):1428-1434